What is the CVSS score of CVE-2016-8358?

CVE-2016-8358 has a CVSS 3.0 base score of 8.5 (High). CVSS vector: CVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:H. EPSS exploitation probability: 0.1%.

Cadd Solis Medication Safety Software CVE-2016-8358

HIGH

Origin Validation Error (CWE-346)

2017-02-13 ics-cert@hq.dhs.gov

Information Disclosure Cadd Solis Medication Safety Software

8.5

CVSS 3.0 · NVD

Severity by source

NVD PRIMARY

8.5 HIGH

AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:H

Attack Vector

Network

Attack Complexity

High

Privileges Required

Low

User Interaction

None

Scope

Changed

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Feb 13, 2017 - 22:59 cve.org

HIGH 8.5

DescriptionCVE.org

An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. The affected software does not verify the identities at communication endpoints, which may allow a man-in-the-middle attacker to gain access to the communication channel between endpoints.

AnalysisAI

An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. Rated high severity (CVSS 8.5), this vulnerability is remotely exploitable. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-346. An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. The affected software does not verify the identities at communication endpoints, which may allow a man-in-the-middle attacker to gain access to the communication channel between endpoints. Affected products include: Smiths-Medical Cadd-Solis Medication Safety Software. Version information: Version 1.0.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.